Dr. Leung Man Kit Garret - Haematology & Haematological Oncology
Specialist in Haematology & Haematological Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Haematology & Haematological OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Hong Kong College of Physicians · Medical degree 2011
- InsuranceBeing compiled|See details
About
Dr. Leung Man Kit Garret is a registered Haematology & Haematological Oncology specialist in Hong Kong.
Education
Specialist in Haematology & Haematological Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2011
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Leung Man Kit Garret? Claim page and update insurance →
FAQ
Is Dr. Leung Man Kit Garret any good?
Dr. Leung Man Kit Garret is a registered Haematology & Haematological Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Leung Man Kit Garret do?
Dr. Leung Man Kit Garret practises in Haematology & Haematological Oncology.
Are you Dr. Leung Man Kit Garret? Claim this page to update and manage.
ClaimResearch and publications
3 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Corrigendum to: Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021 [Blood Cell Therapy. 2024; 7(4): 129-137. doi:10.31547/bct-2024-020].Blood cell therapy · 2025
- Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021.Blood cell therapy · 2024
- Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese.Frontiers in immunology · 2022
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer